Radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma

類似資料

• Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
  著者:: Fayette, Jérôme, 等
  出版事項: (2016)
• An effective and well-tolerated strategy in recurrent and/or metastatic head and neck cancer: successive lines of active chemotherapeutic agents
  著者:: Péron, Julien, 等
  出版事項: (2014)
• Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule
  著者:: Pêtre, Adeline, 等
  出版事項: (2018)
• Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
  著者:: Bauml, Joshua M, 等
  出版事項: (2018)
• Every Week Counts
  著者:: Budin, Wendy C., 等
  出版事項: (2013)